Sept 22 (Reuters) – Swiss drugmaker Roche said on Tuesday its experimental dual-acting obesity drug helped overweight or obese patients with type 2 diabetes lower blood sugar levels and lose an
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
* Task force aims to halt dual-use technology flows and illegal revenue streams * CENTCOM…
VIDEO SHOWS: HIGHLIGHTS OF THE HONG KONG OPEN SEMI-FINALS RESENDING WITH COMPLETE SCRIPT SHOWS: HONG…
EDINBURGH, Nov 7 (Reuters) - New Zealand kept up their unbeaten record against Scotland, blowing…
Victor Wembanyama and the San Antonio Spurs will look to stretch the NBA's longest winning…
VIDEO SHOWS: HIGHLIGHTS OF THE HONG KONG OPEN SEMI-FINALS COMPLETE SHOTLIST AND SCRIPT TO FOLLOW…
CAIRO, Nov 7 (Reuters) - Syria has no plans to send military forces to Yemen,…